ABT fundamentals
ABBOTT LABORATORIES revenue breakdown overview
ABBOTT LABORATORIES revenue for the last year amounted to 41.95 B USD, the most of which — 18.99 B USD — came from its highest performing source at the moment, Medical Devices, the year earlier bringing 16.89 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought ABBOTT LABORATORIES 16.32 B USD, and the year before that — 15.45 B USD.
By source
2017
2018
2019
2020
2021
2022
2023
2024
0.00
11.00 B
22.00 B
33.00 B
44.00 B
Medical Devices
Diagnostic Products
Nutritional Products
Established Pharmaceutical Products
Other
Cardiovascular and Neuromodulation
Currency: USD
2017
2018
2019
2020
2021
2022
2023
2024
Medical Devices
11.79 B
14.37 B
14.69 B
16.89 B
18.99 B
Diagnostic Products
10.80 B
15.64 B
16.58 B
9.99 B
9.34 B
Nutritional Products
7.65 B
8.29 B
7.46 B
8.15 B
8.41 B
Established Pharmaceutical Products
4.30 B
4.72 B
4.91 B
5.07 B
5.19 B
Other
66.00 M
52.00 M
11.00 M
14.00 M
16.00 M
Cardiovascular and Neuromodulation
—
—
—
—
—
By country
2017
2018
2019
2020
2021
2022
2023
2024
0.00
11.00 B
22.00 B
33.00 B
44.00 B
United States
All Other Countries
Germany
China
India
Switzerland
Japan
Netherlands
Canada
Russia
Other
Currency: USD
2017
2018
2019
2020
2021
2022
2023
2024
United States
13.02 B
16.64 B
18.14 B
15.45 B
16.32 B
All Other Countries
12.58 B
15.52 B
14.84 B
14.08 B
14.85 B
Germany
2.11 B
2.57 B
2.34 B
2.35 B
2.54 B
China
1.97 B
2.39 B
2.13 B
2.25 B
2.11 B
India
1.32 B
1.56 B
1.65 B
1.75 B
1.82 B
Switzerland
1.14 B
1.31 B
1.34 B
1.64 B
1.75 B
Japan
1.39 B
1.70 B
1.93 B
1.51 B
1.44 B
Netherlands
1.08 B
—
—
1.07 B
1.12 B
Canada
—
1.39 B
1.28 B
—
—
Russia
—
—
—
—
—
Other
—
—
—
—
—